Latest News
  • 11
    New Strategic Partnership Novartis- Pharmathen
    The purpose of the agreement is to promote innovative inhalable drugs for treating Chronic Obstructive Pulmonary Disease (COPD).
    Read more »
  • 6/24/2014 | Pharmathen: New award for Employment Growth from ACCI (ΕΒΕΑ)
    The company received an award for Employment Growth from the Athens Chamber of Commerce and Industry (ΕVΕΑ) 2014, at a special event held on Monday, 23 June 2014. According to the organizers, this particular award is extremely important for businesses and entrepreneurs, as it comes at a time of recession and dwindling employment.
    Read more »
  • 6/18/2014 | LAI Technology: Breakthrough Innovation by Pharmathen
    The Greek Pharmaceutical Industry Pharmathen has taken its place on the world map of innovation in the pharmaceutical field, following the most recent achievement by the department of Research and Development of innovative healthcare products, that concerns the development of Long Acting Injectable (LAI) Technology – sustained-release injectable products.
    Read more »